The Effect of Vorinostat on the Development of Resistance to Doxorubicin in Neuroblastoma

Histone deacetylase (HDAC) inhibitors, especially vorinostat, are currently under investigation as potential adjuncts in the treatment of neuroblastoma. The effect of vorinostat co-treatment on the development of resistance to other chemotherapeutic agents is unknown. In the present study, we treate...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Lautz, Timothy B., Jie, Chunfa, Clark, Sandra, Naiditch, Jessica A., Jafari, Nadereh, Qiu, Yi-Yong, Zheng, Xin, Chu, Fei, Madonna, Mary Beth
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2012
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3400660/
https://ncbi.nlm.nih.gov/pubmed/22829886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0040816
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items